Authors: BARNES NC HALLETT C HARRIS TAJ

Citation: Nc. Barnes et al., CLINICAL-EXPERIENCE WITH FLUTICASONE PROPIONATE IN ASTHMA - A METAANALYSIS OF EFFICACY AND SYSTEMIC ACTIVITY COMPARED WITH BUDESONIDE AND BECLOMETHASONE DIPROPIONATE AT HALF THE MICROGRAM DOSE OR LESS, Respiratory medicine, 92(1), 1998, pp. 95-104

Authors: LLEWELLYNJONES CG HARRIS TAJ STOCKLEY RA

Citation: Cg. Llewellynjones et al., EFFECT OF FLUTICASONE PROPIONATE ON SPUTUM OF PATIENTS WITH CHRONIC-BRONCHITIS AND EMPHYSEMA, American journal of respiratory and critical care medicine, 153(2), 1996, pp. 616-621

Authors: RINGDAL N SWINBURN P BACKMAN R PLASCHKE P SIPS AP KJAERSGAARD P BRATTEN G HARRIS TAJ

Citation: N. Ringdal et al., A BLINDED COMPARISON OF FLUTICASONE PROPIONATE WITH BUDESONIDE VIA POWDER DEVICES IN ADULT PATIENTS WITH MODERATE-TO-SEVERE ASTHMA - A CLINICAL-EVALUATION, Mediators of inflammation, 5(5), 1996, pp. 382-389

Authors: LORENTZEN KA VANHELMOND JLM BAUER K LANGAKER KE BONIFAZI F HARRIS TAJ

Citation: Ka. Lorentzen et al., FLUTICASONE PROPIONATE 1 MG DAILY AND BECLOMETHASONE DIPROPIONATE 2 MG DAILY - A COMPARISON OVER 1 YR, Respiratory medicine, 90(10), 1996, pp. 609-617

Authors: AYRES JG BATEMAN ED LUNDBACK B HARRIS TAJ

Citation: Jg. Ayres et al., HIGH-DOSE FLUTICASONE PROPIONATE, 1 MG DAILY, VERSUS FLUTICASONE PROPIONATE, 2 MG DAILY, OR BUDESONIDE, 1.6 MG DAILY, IN PATIENTS WITH CHRONIC SEVERE ASTHMA, The European respiratory journal, 8(4), 1995, pp. 579-586